Theophylline Prevents Dexamethasone-Induced Atrophy in C2C12 Myotubes

J Nutr Sci Vitaminol (Tokyo). 2023;69(4):284-291. doi: 10.3177/jnsv.69.284.

Abstract

Skeletal muscle mass is maintained by a balance between the synthesis and degradation of muscle proteins, the collapse of which causes muscle wasting. The prevention of muscle wasting improves the quality of life and extends a healthy life. The methyl xanthine theophylline showed strong preventive activity against dexamethasone-induced muscle atrophy, as determined using the expression level of myosin heavy chain in C2C12 myotubes. Mechanistically, theophylline inhibited the expression of ubiquitin ligases MuRF1 and Cbl-b, but not that of atrogin-1. Furthermore, theophylline inhibits glucocorticoid receptor translocation to the nucleus. A pull-down assay using a theophylline probe revealed that theophylline and dexamethasone competitively interacted with the glucocorticoid receptor, suggesting an antagonistic activity of theophylline on glucocorticoid receptors. Additionally, theophylline inhibited the dexamethasone-induced phosphorylation of p38 and FoxO3a in C2C12 myotubes. These findings suggest that theophylline is an effective food ingredient in the prevention of glucocorticoid-induced skeletal muscle atrophy.

Keywords: C2C12 myotubes; glucocorticoid receptor; muscle atrophy; oxidative stress; theophylline.

MeSH terms

  • Dexamethasone / adverse effects
  • Humans
  • Muscle Fibers, Skeletal
  • Muscular Atrophy / chemically induced
  • Muscular Atrophy / prevention & control
  • Quality of Life*
  • Receptors, Glucocorticoid
  • Theophylline* / pharmacology

Substances

  • Theophylline
  • Receptors, Glucocorticoid
  • Dexamethasone